Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III ERCC1-stratified platinum vs non-platinum chemotherapy in advanced NSCLC
2007-007639-17Phase 3Terminated
- Sponsor
- University College London
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin, pemetrexed and paclitaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University College London. Primary endpoint: Overall survival in ERCC1-positive patients. Started May 2008; status: terminated.
02
Drugs
cisplatinpemetrexedpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-007639-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007639-17.